Cargando…
Radiosensitization in prostate cancer: mechanisms and targets
Prostate cancer is the second most commonly diagnosed cancer in American men over the age of 45 years and is the third most common cause of cancer related deaths in American men. In 2012 it is estimated that 241,740 men will be diagnosed with prostate cancer and 28,170 men will succumb to prostate c...
Autores principales: | Palacios, Diego A, Miyake, Makito, Rosser, Charles J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583813/ https://www.ncbi.nlm.nih.gov/pubmed/23351141 http://dx.doi.org/10.1186/1471-2490-13-4 |
Ejemplares similares
-
Focal cryosurgical ablation of the prostate: a single institute’s perspective
por: Hale, Zachary, et al.
Publicado: (2013) -
Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy
por: Palacios, Diego Aguilar, et al.
Publicado: (2013) -
Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
por: Alcorn, Sara, et al.
Publicado: (2013) -
Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers
por: Nicolae, Alexandru Mihai, et al.
Publicado: (2016) -
Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
por: Mukha, Anna, et al.
Publicado: (2021)